Predictors of CPAP failure after less-invasive surfactant administration in preterm infants

• Published in: Frontiers in pediatrics Vol. 12; p. 1444906
• Main Authors: Alsina-Casanova, Miguel, Brito, Nerea, Balcells-Esponera, Carla, Herranz-Barbero, Ana, Teresa-Palacio, Marta, Soler-García, Aleix, Agustí, Carmen, Brullas, Guillem, Clotet, Jordi, Carrasco, Cristina, Salvia, Dolors, Aldecoa-Bilbao, Victoria
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 27-08-2024
• Subjects: CPAP failure; less-invasive surfactant administration; lung ultrasound; neonatal respiratory distress syndrome; Pediatrics; preterm infant; less-invasive surfactant administration; preterm infant; CPAP failure; lung ultrasound; neonatal respiratory distress syndrome
• ISSN: 2296-2360; 2296-2360
• DOI: 10.3389/fped.2024.1444906

Less-invasive surfactant administration (LISA) is associated with better respiratory outcomes in preterm infants with respiratory distress syndrome. However, mechanical ventilation (MV) shortly after the LISA procedure has been related to lower survival. This study aimed to analyze the trends and main predictors of continuous positive airway pressure (CPAP) failure after LISA.
Preterm infants born between 23
and 33
weeks gestational age (GA) in two level III neonatal units who received surfactant were included (2017-2022). Demographic data, lung ultrasound (LUS) scores, the saturation/fraction of inspired oxygen (SF) ratio, technique, time to surfactant administration, and the main neonatal outcomes were collected.
Over the study period, 289 inborn preterm infants received surfactant, 174 with the LISA method (60.2%). Patients who received surfactant after intubation in the delivery room (
 = 56) were more immature and exhibited worse outcomes. Patients who received surfactant via an endotracheal tube in the neonatal intensive care unit (
 = 59) had higher LUS scores and a lower SF ratio than those treated with LISA. The LISA method was associated with less death or bronchopulmonary dysplasia (BPD), with an adjusted odds ratio (aOR) = 0.37 [95% confidence interval (CI), 0.18-0.74,
 = 0.006]. CPAP failure after LISA (defined as the need for intubation and MV in the first 72 h of life) occurred in 38 patients (21.8%), inversely proportional to GA (38.7% at 23-26 weeks, 26.3% at 27-30 weeks, and 7.9% at 30-33 weeks (
 < 0.001). CPAP failure after LISA was significantly related to death, with an aOR = 12.0 (95% CI, 3.0-47.8,
 < 0.001), and moderate to severe BPD, with an aOR = 2.9 (95% CI, 1.1-8.0,
 = 0.035), when adjusting for GA. The best predictors of CPAP failure after LISA were GA, intrauterine growth restriction, temperature at admission, the SF ratio, and the LUS score, with a Nagelkerke's
= 0.458 (
 < 0.001). The predictive model showed an area under the curve = 0.84 (95% CI, 0.75-0.93,
 < 0.001).
CPAP failure after LISA is still common in extremely preterm infants, leading to an increase in death or disability. Clinicians must acknowledge the main risk factors of CPAP failure to choose wisely the right patient and the best technique. LUS and the SF ratio at admission can be useful when making these decisions.